Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma
Clinical trial NCT00906841 · TERMINATED
Trial details
- NCT number
- NCT00906841
- Sponsor
- French Innovative Leukemia Organisation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2016-03-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.